Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5–11 years with underlying diseases: A prospective observational study
- Resource Type
- Article
- Source
- In
Journal of Infection and Chemotherapy August 2024 30(8):773-779 - Subject
- Language
- ISSN
- 1341-321X